Navigation Links
Kewaunee Scientific Announces First Quarter Results and Quarterly Dividend
Date:8/22/2007

ooking statements involve known and unknown risks, uncertainties and other factors that could significantly impact results or achievements expressed or implied by such forward-looking statements. These factors include, but are not limited to, economic, competitive, governmental, and technological factors affecting the Company's operations, markets, products, services, and prices.

Consolidated Statements of Operations [unaudited]

(in thousands, except per share data)

Three Months Ended

July 31 July 31

2007 2006

Net sales $20,784 $19,294

Cost of products sold 16,521 16,166

Gross profit 4,263 3,128

Operating expenses 3,148 2,637

Operating earnings 1,115 491

Other income 3 18

Interest expense (110) (187)

Earnings before income taxes 1,008 322

Income tax expense 312 78

Earnings before minority interests 696 244

Minority interests in subsidiaries 22 111

Net earnings $674 $133

Net earnings per share

Basic $0.27 $0.05

Diluted $0.27 $0.05

Weighted average number of common

shares outstanding (in thousands)

Basic 2,502 2,492

Diluted 2,521 2,493

Condensed Consolidated Balance Sheets

(in thousands)


'/>"/>

SOURCE Kewaunee Scientific Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. UW-Madisons Beebe wins scientific award
2. Researchers say scientific reporting needs more perspective, less hype
3. Wisconsin stands at the center of scientific efforts to avert flu epidemics
4. Growth prompts new location for scientific instrument manufacturer
5. UW stem cell guru outlines scientific and political future
6. Wisconsin biotech sector featured in scientific magazine
7. Scientific Protein Laboratories Acquired by New York firm
8. GenTel Appoints Burke to its Scientific Advisory Board
9. Speaker announces business members of IT Task Force
10. Doyle announces technology tax credits for Berbee
11. Doyle announces new energy, global warming policies
Post Your Comments:
*Name:
*Comment:
*Email: